VEDOLIZUMAB PROVIDES CLINICAL BENEFIT OVER ONE YEAR IN PATIENTS WITH REFRACTORY INFLAMMATORY BOWEL DISEASE - RESULTS OF A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY

Raja Atreya  1     Daniel C. Baumgart  2     Tony Bruns  3     Axel Dignass  4     Katrin Ende  5     Jochen Hampe     Franz Hartmann     Christian Langbein     Jochen Maul     Markus F. Neurath     Jan C. Preiss     Renate Schmelz     Carsten Schmidt     Hermann Schulze     Britta Siegmund     Niels Teich     Ulrike von Arnim     Andreas Stallmach    
1 University Erlangen-Nuremberg, Medical Department 1, Erlangen, Germany
2 Charité Medical School - Humboldt-University of Berlin, Department of Gastroenterology and Hepatology, Berlin, Germany
3 Jena University Hospital, Internal Medicine, Jena, Germany
4 Agaplesion Markus Krankenhaus, Medizinische Klinik I, Frankfurt, Germany
5 HELIOS Hosp

Conference
UEG Week 2016

Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing